These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21820414)

  • 1. Proteomic analysis of cancer stem cells in human prostate cancer cells.
    Lee EK; Cho H; Kim CW
    Biochem Biophys Res Commun; 2011 Aug; 412(2):279-85. PubMed ID: 21820414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.
    Patrawala L; Calhoun-Davis T; Schneider-Broussard R; Tang DG
    Cancer Res; 2007 Jul; 67(14):6796-805. PubMed ID: 17638891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
    Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
    In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.
    Rowehl RA; Crawford H; Dufour A; Ju J; Botchkina GI
    Cancer Genomics Proteomics; 2008; 5(6):301-10. PubMed ID: 19287071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics.
    Noto Z; Yoshida T; Okabe M; Koike C; Fathy M; Tsuno H; Tomihara K; Arai N; Noguchi M; Nikaido T
    Oral Oncol; 2013 Aug; 49(8):787-95. PubMed ID: 23768762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
    Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
    Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
    Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
    In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.
    Zhang H; Li W; Nan F; Ren F; Wang H; Xu Y; Zhang F
    Biochem Biophys Res Commun; 2011 Jan; 404(1):273-8. PubMed ID: 21130073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer stem cells and their potential roles in metastasis.
    Li H; Tang DG
    J Surg Oncol; 2011 May; 103(6):558-62. PubMed ID: 21480250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer stem/progenitor cells: identification, characterization, and implications.
    Tang DG; Patrawala L; Calhoun T; Bhatia B; Choy G; Schneider-Broussard R; Jeter C
    Mol Carcinog; 2007 Jan; 46(1):1-14. PubMed ID: 16921491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells.
    Miki J; Rhim JS
    Prostate Cancer Prostatic Dis; 2008; 11(1):32-9. PubMed ID: 17984999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.
    Patrawala L; Calhoun T; Schneider-Broussard R; Li H; Bhatia B; Tang S; Reilly JG; Chandra D; Zhou J; Claypool K; Coghlan L; Tang DG
    Oncogene; 2006 Mar; 25(12):1696-708. PubMed ID: 16449977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer.
    Shen C; Xiang M; Nie C; Hu H; Ma Y; Wu H
    Acta Otolaryngol; 2013 Nov; 133(11):1219-26. PubMed ID: 23837451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly r(C) binding protein-1 is central to maintenance of cancer stem cells in prostate cancer cells.
    Chen Q; Cai ZK; Chen YB; Gu M; Zheng DC; Zhou J; Wang Z
    Cell Physiol Biochem; 2015; 35(3):1052-61. PubMed ID: 25661993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of human adipose stem cells in a cancer stem cell-like gastric cancer cell model.
    Liu G; Neumeister M; Reichensperger J; Yang RD
    Int J Oncol; 2013 Oct; 43(4):1301-9. PubMed ID: 23900519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
    Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
    J Pathol; 2007 Oct; 213(2):152-60. PubMed ID: 17708598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics for the identification of new prostate cancer biomarkers.
    Ornstein DK; Tyson DR
    Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of CD90+ cancer stem cells in human liver cancer.
    Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST
    Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.